Japan Real Estate Investment Corporation (JREIF)

Marinus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 2, 2025	Mar 31, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Market Capitalization	5,921	5,098	5,671	5,554	5,716	8,296
Market Cap Growth	0.73%	-10.11%	2.11%	-2.83%	-31.10%	17.41%
Enterprise Value	8,966	8,000	8,799	8,481	8,679	11,813
Last Close Price	800.00	771.91	776.28	776.28	884.05	1120.00
PE Ratio	23.50	20.23	21.68	24.96	25.19	28.54
PS Ratio	10.33	8.90	9.67	10.93	11.21	12.90
PB Ratio	1.63	1.41	1.50	1.54	1.60	1.79
P/OCF Ratio	12.99	11.18	11.04	13.85	12.06	18.51
EV/Sales Ratio	15.45	13.96	15.01	16.69	17.03	18.36
EV/EBITDA Ratio	24.58	22.27	23.67	26.64	26.30	27.63
EV/EBIT Ratio	31.88	28.81	30.78	36.10	35.73	37.78
Debt / Equity Ratio	0.88	0.88	0.85	0.84	0.82	0.81
Debt / EBITDA Ratio	8.82	8.82	8.60	9.47	8.87	8.80
Asset Turnover	0.08	0.08	0.08	0.07	0.07	0.07
Quick Ratio	0.25	0.25	0.19	0.28	0.26	0.49
Current Ratio	0.31	0.31	0.25	0.35	0.35	0.59
Return on Equity (ROE)	6.97%	6.97%	6.94%	6.29%	6.35%	6.29%
Return on Assets (ROA)	2.38%	2.38%	2.41%	2.12%	2.18%	2.17%
Return on Capital (ROIC)	2.55%	2.55%	2.57%	2.27%	2.34%	2.33%
Earnings Yield	4.25%	4.94%	4.61%	4.01%	3.97%	3.50%
Dividend Yield	4.20%	-	-	4.08%	3.58%	-
Payout Ratio	93.13%	93.13%	92.75%	96.55%	95.99%	96.45%
Buyback Yield / Dilution	-0.06%	-	-1.40%	-1.30%	-	-
Total Shareholder Return	4.15%	-	-1.40%	2.78%	3.58%	-

Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.